Wells Fargo’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $85.9K | Buy |
|
|||||
|
2025
Q1 | $79.1K | Buy |
|
|||||
|
2024
Q4 | $137K | Buy |
|
|||||
|
2024
Q3 | $149K | Sell |
|
|||||
|
2024
Q2 | $142K | Sell |
|
|||||
|
2024
Q1 | $195K | Buy |
|
|||||
|
2023
Q4 | $71.2K | Buy |
|
|||||
|
2023
Q3 | $44.9K | Sell |
|
|||||
|
2023
Q2 | $99.3K | Buy |
|
|||||
|
2023
Q1 | $35.4K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $18K | Sell |
|
|||||
|
2022
Q2 | $23K | Sell |
|
|||||
|
2022
Q1 | $212K | Sell |
|
|||||
|
2021
Q4 | $470K | Sell |
|
|||||
|
2021
Q3 | $1.2M | Buy |
|
|||||
|
2021
Q2 | $562K | Buy |
|
|||||
|
2021
Q1 | $435K | Sell |
|
|||||
|
2020
Q4 | $1.33M | Buy |
|
|||||
|
2020
Q3 | $632K | Sell |
|
|||||
|
2020
Q2 | $791K | Buy |
|
|||||
|
2020
Q1 | $329K | Buy |
|
|||||
|
2019
Q4 | $343K | Sell |
|
|||||
|
2019
Q3 | $695K | Buy |
|
|||||
|
2019
Q2 | $438K | Buy |
|
|||||
|
2019
Q1 | $96K | Buy |
|
|||||
|
2018
Q4 | $70K | Buy |
|